PROCEPT BioRobotics Corp (PRCT)
86.46
-1.08
(-1.23%)
USD |
NASDAQ |
Jan 08, 16:00
86.42
-0.04
(-0.05%)
Pre-Market: 09:02
PROCEPT BioRobotics SG&A Expense (Quarterly): 42.69M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intuitive Surgical Inc | 510.60M |
| Boston Scientific Corp | 1.562B |
| Teleflex Inc | 247.26M |
| RxSight Inc | 25.61M |
| Perspective Therapeutics Inc | 6.975M |